293 related articles for article (PubMed ID: 12654055)
41. Daclizumab induction therapy associated with tacrolimus-MMF has better outcome compared with tacrolimus-MMF alone in pediatric living donor liver transplantation.
Schuller S; Wiederkehr JC; Coelho-Lemos IM; Avilla SG; Schultz C
Transplant Proc; 2005 Mar; 37(2):1151-2. PubMed ID: 15848653
[TBL] [Abstract][Full Text] [Related]
42. Randomized trial of mycophenolate mofetil versus enteric-coated mycophenolate sodium in primary renal transplant recipients given tacrolimus and daclizumab/thymoglobulin: one year follow-up.
Ciancio G; Burke GW; Gaynor JJ; Roth D; Sageshima J; Kupin W; Tueros L; Hanson L; Rosen A; Ruiz P; Miller J
Transplantation; 2008 Jul; 86(1):67-74. PubMed ID: 18622280
[TBL] [Abstract][Full Text] [Related]
43. Successful rescue therapy with mycophenolate mofetil in kidney transplantation improves the long-term graft survival.
Kahu J; Lõhmus A; Ilmoja M; Kirsimägi U; Timberg G; Peetsalu A
Medicina (Kaunas); 2007; 43(12):953-8. PubMed ID: 18182839
[TBL] [Abstract][Full Text] [Related]
44. Ten-year results of a randomized trial comparing tacrolimus versus cyclosporine a in combination with mycophenolate mofetil after heart transplantation.
Guethoff S; Meiser BM; Groetzner J; Eifert S; Grinninger C; Ueberfuhr P; Reichart B; Hagl C; Kaczmarek I
Transplantation; 2013 Feb; 95(4):629-34. PubMed ID: 23423270
[TBL] [Abstract][Full Text] [Related]
45. Outcomes of two-drug maintenance immunosuppression for pediatric renal transplantation: 10-yr follow-up in a single center.
Michael M; Minard CG; Kale AS; Brewer ED
Pediatr Transplant; 2016 Feb; 20(1):49-58. PubMed ID: 26916966
[TBL] [Abstract][Full Text] [Related]
46. A study comparing mycophenolate mofetil to azathioprine in simultaneous pancreas-kidney transplantation.
Odorico JS; Pirsch JD; Knechtle SJ; D'Alessandro AM; Sollinger HW
Transplantation; 1998 Dec; 66(12):1751-9. PubMed ID: 9884272
[TBL] [Abstract][Full Text] [Related]
47. Influence of tacrolimus plus mycophenolate mofetil regimens on acute rejection rate and diabetes mellitus development in renal transplant recipients.
Demirbaş A; Tuncer M; Yavuz A; Gürkan A; Kaçar S; Cetinkaya R; Tekin S; Akbaş SH; Akaydin M; Ersoy F; Yakupoğlu G
Transplant Proc; 2004; 36(1):175-7. PubMed ID: 15013338
[TBL] [Abstract][Full Text] [Related]
48. Controlling treatment allocation bias in a registry analysis when comparing calcineurin inhibitors.
Bunnapradist S; Takemoto SK
Transplant Proc; 2003 Nov; 35(7):2407-8. PubMed ID: 14611971
[TBL] [Abstract][Full Text] [Related]
49. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
[TBL] [Abstract][Full Text] [Related]
50. Long-term dosing patterns of enteric-coated mycophenolate sodium or mycophenolate mofetil with tacrolimus after renal transplantation.
Langone A; Shihab F; Pankewycz O; Doria C; Wiland A; McCague K; Chan L
Clin Transplant; 2014 Sep; 28(9):961-7. PubMed ID: 24893821
[TBL] [Abstract][Full Text] [Related]
51. Mycophenolate mofetil in pediatric renal transplantation.
Otukesh H; Sharifian M; Basiri A; Simfroosh N; Hoseini R; Sedigh N; Golnari P; Rezai M; Fereshtenejad M
Transplant Proc; 2005 Sep; 37(7):3012-5. PubMed ID: 16213289
[TBL] [Abstract][Full Text] [Related]
52. Mycophenolate mofetil in pediatric renal transplantation: a single center experience.
Raheem OA; Kamel MH; Daly PJ; Mohan P; Little DM; Awan A; Hickey DP
Pediatr Transplant; 2011 May; 15(3):240-4. PubMed ID: 21492350
[TBL] [Abstract][Full Text] [Related]
53. Immunosuppression with generic tacrolimus and mycophenolate mofetil in renal transplant recipients: preliminary report in Chile.
Müller H; Solari S; Zuñiga C; Pedreros C; Troncoso J; Morente C; Ovalle R; Acosta P; Chavez T; Albornoz E
Transplant Proc; 2008 Apr; 40(3):705-7. PubMed ID: 18454992
[TBL] [Abstract][Full Text] [Related]
54. Mycophenolate mofetil in pediatric heart transplant recipients: a single-center experience.
Dipchand AI; Benson L; McCrindle BW; Coles J; West L
Pediatr Transplant; 2001 Apr; 5(2):112-8. PubMed ID: 11328549
[TBL] [Abstract][Full Text] [Related]
55. Daclizumab induction, tacrolimus, mycophenolate mofetil and steroids as an immunosuppression regimen for primary kidney transplant recipients.
Ciancio G; Burke GW; Suzart K; Roth D; Kupin W; Rosen A; Olson L; Esquenazi V; Miller J
Transplantation; 2002 Apr; 73(7):1100-6. PubMed ID: 11965039
[TBL] [Abstract][Full Text] [Related]
56. Impact of mycophenolate mofetil on recurrent rejection in kidney transplant patients.
Vasquez EM; Sifontis NM; Pollak R; Benedetti E
Clin Transplant; 2001 Aug; 15(4):253-7. PubMed ID: 11683819
[TBL] [Abstract][Full Text] [Related]
57. Patterns of cytomegalovirus infection in simultaneous kidney-pancreas transplant recipients receiving tacrolimus, mycophenolate mofetil, and prednisone with ganciclovir prophylaxis.
Lo A; Stratta RJ; Egidi MF; Shokouh-Amiri MH; Grewal HP; Kisilisik AT; Trofe J; Alloway RR; Gaber LW; Gaber AO
Transpl Infect Dis; 2001 Mar; 3(1):8-15. PubMed ID: 11429034
[TBL] [Abstract][Full Text] [Related]
58. Alemtuzumab with corticosteroid minimization for pediatric deceased donor renal transplantation: a seven-yr experience.
Supe-Markovina K; Melquist JJ; Connolly D; DiCarlo HN; Waltzer WC; Fine RN; Darras FS
Pediatr Transplant; 2014 Jun; 18(4):363-8. PubMed ID: 24712738
[TBL] [Abstract][Full Text] [Related]
59. Adult-size kidneys without acute tubular necrosis provide exceedingly superior long-term graft outcomes for infants and small children: a single center and UNOS analysis. United Network for Organ Sharing.
Sarwal MM; Cecka JM; Millan MT; Salvatierra O
Transplantation; 2000 Dec; 70(12):1728-36. PubMed ID: 11152105
[TBL] [Abstract][Full Text] [Related]
60. A multicenter, open-label, comparative trial of two daclizumab dosing strategies vs. no antibody induction in combination with tacrolimus, mycophenolate mofetil, and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients: interim analysis.
Stratta RJ; Alloway RR; Hodge E; Lo A;
Clin Transplant; 2002 Feb; 16(1):60-8. PubMed ID: 11982617
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
